| 1 | [SID103759741] | Active | Ki | 1e-05 | Inhibition of HIV protease [AID160300, Type: Literature] | Pol polyprotein [gi:75593047] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 1e-05 [uM] | | BioAssay | Inhibition of HIV protease | | AID | 160300 | | BioAssay type | Literature | | Target | Pol polyprotein [gi:75593047] | | PubMed | 10866371 | | Data Table |  |
|
| 2 | [SID103759741] | Active | Ki | 7e-05 | Inhibition of wild-type HIV1 BH10 protease expressed in Escherichia coli by spectrophotometric assay [AID343014, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 7e-05 [uM] | | BioAssay | Inhibition of wild-type HIV1 BH10 protease expressed in Escherichia coli by spectrophotometric assay | | AID | 343014 | | BioAssay type | Literature | | Target | | | PubMed | 18598016 | | Data Table |  |
|
| 3 | [SID103759741] | Active | Ki | 0.00014 | Dissociation constant obtained by inhibition of Wild-type protease [AID219260, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.00014 [uM] | | BioAssay | Dissociation constant obtained by inhibition of Wild-type protease | | AID | 219260 | | BioAssay type | Literature | | Target | | | PubMed | 10978186 | | Data Table |  |
|
| 4 | [SID103759741] | Active | Ki | 0.00017 | Inhibition of HIV-1 Protease activity [AID161524, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.00017 [uM] | | BioAssay | Inhibition of HIV-1 Protease activity | | AID | 161524 | | BioAssay type | Literature | | Target | | | PubMed | 15013001 | | Data Table |  |
|
| 5 | [SID103759741] | Active | Ki | 0.00023 | Inhibitory concentration against HIV-1 protease [AID160481, Type: Literature] | Pol polyprotein [gi:75593047] |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.00023 [uM] | | BioAssay | Inhibitory concentration against HIV-1 protease | | AID | 160481 | | BioAssay type | Literature | | Target | Pol polyprotein [gi:75593047] | | PubMed | 11543677 | | Data Table |  |
|
| 6 | [SID103759741] | Active | Ki | 0.00028 | Inhibition of HIV1 protease [AID282343, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.00028 [uM] | | BioAssay | Inhibition of HIV1 protease | | AID | 282343 | | BioAssay type | Literature | | Target | | | PubMed | 15615516 | | Data Table |  |
|
| 7 | [SID103759741] | Active | Ki | 0.000306 | Inhibition of HIV1 protease [AID374591, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.000306 [uM] | | BioAssay | Inhibition of HIV1 protease | | AID | 374591 | | BioAssay type | Literature | | Target | | | PubMed | 17638694 | | Data Table |  |
|
| 8 | [SID103759741] | Active | Ki | 0.00054 | Inhibition constant against HIV-1 Protease [AID160455, Type: Literature] | Pol polyprotein [gi:75593047] |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.00054 [uM] | | BioAssay | Inhibition constant against HIV-1 Protease | | AID | 160455 | | BioAssay type | Literature | | Target | Pol polyprotein [gi:75593047] | | PubMed | 12459011 | | Data Table |  |
|
| 9 | [SID103759741] | Active | Ki | 0.00054 | Inhibition constant for human immunodeficiency virus type 1 protease [AID238682, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.00054 [uM] | | BioAssay | Inhibition constant for human immunodeficiency virus type 1 protease | | AID | 238682 | | BioAssay type | Literature | | Target | | | PubMed | 15537350 | | Data Table |  |
|
| 10 | [SID103759741] | Active | Ki | 0.000931 | Inhibition of HIV1 protease [AID321660, Type: Literature] | |   View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.000931 [uM] | | BioAssay | Inhibition of HIV1 protease | | AID | 321660 | | BioAssay type | Literature | | Target | | | PubMed | 17981045 | | Data Table |  |
|
| 11 | [SID103759741] | Active | Kd | 0.00164 | Equilibrium constant for the interaction between inhibitor and HIV-1 Protease [AID162706, Type: Literature] | Pol polyprotein [gi:75593047] |   View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Kd | 0.00164 [uM] | | BioAssay | Equilibrium constant for the interaction between inhibitor and HIV-1 Protease | | AID | 162706 | | BioAssay type | Literature | | Target | Pol polyprotein [gi:75593047] | | PubMed | 12459011 | | Data Table |  |
|
| 12 | [SID103759741] | Active | Kd | 0.00164 | Binding affinity for human immunodeficiency virus type 1 protease [AID238043, Type: Literature] | |   View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Kd | 0.00164 [uM] | | BioAssay | Binding affinity for human immunodeficiency virus type 1 protease | | AID | 238043 | | BioAssay type | Literature | | Target | | | PubMed | 15537350 | | Data Table |  |
|
| 13 | [SID103759741] | Active | EC50 | 0.00167 | Antiviral activity against wild type HIV1 subtype C infected in human cord blood mononuclear cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay [AID546994, Type: Literature] | |   View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.00167 [uM] | | BioAssay | Antiviral activity against wild type HIV1 subtype C infected in human cord blood mononuclear cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay | | AID | 546994 | | BioAssay type | Literature | | Target | | | PubMed | 20404123 | | Data Table |  |
|
| 14 | [SID103759741] | Active | IC50 | 0.0019 | Inhibition of recombinant wild type HIV1 protease assessed as hydrolysis of fluorogenic substrate [AID458605, Type: Literature] | |   View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.0019 [uM] | | BioAssay | Inhibition of recombinant wild type HIV1 protease assessed as hydrolysis of fluorogenic substrate | | AID | 458605 | | BioAssay type | Literature | | Target | | | PubMed | 20108932 | | Data Table |  |
|
| 15 | [SID103759741] | Active | IC50 | 0.002 | Antiviral activity against Human immunodeficiency virus type 1 (BRU ISOLATE) after 13 months [AID521548, Type: Literature] | |   View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.002 [uM] | | BioAssay | Antiviral activity against Human immunodeficiency virus type 1 (BRU ISOLATE) after 13 months | | AID | 521548 | | BioAssay type | Literature | | Target | | | PubMed | 18227188 | | Data Table |  |
|
| 16 | [SID103759741] | Active | IC50 | 0.002 | Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as reverse transcriptase activity after 5 days by MTT assay [AID371125, Type: Literature] | |   View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.002 [uM] | | BioAssay | Antiviral activity against HIV1 LAI infected in human CEM-SS cells assessed as reverse transcriptase activity after 5 days by MTT assay | | AID | 371125 | | BioAssay type | Literature | | Target | | | PubMed | 17950955 | | Data Table |  |
|
| 17 | [SID103759741] | Active | Ki | 0.0021 | Inhibition of HIV1 recombinant protease L10I/I15V/E35D/N37S/R41K/I62V/L63P/A71V/G73S/L90M mutant expressed in Escherichia coli by spectrophotometric assay [AID343019, Type: Literature] | |   View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.0021 [uM] | | BioAssay | Inhibition of HIV1 recombinant protease L10I/I15V/E35D/N37S/R41K/I62V/L63P/A71V/G73S/L90M mutant expressed in Escherichia coli by spectrophotometric assay | | AID | 343019 | | BioAssay type | Literature | | Target | | | PubMed | 18598016 | | Data Table |  |
|
| 18 | [SID103759741] | Active | Kd | 0.00299 | Binding affinity to Human immunodeficiency virus 1 protease by SPR biosensor interaction analysis at pH 5.1 [AID673197, Type: Literature] | |   View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Kd | 0.00299 [uM] | | BioAssay | Binding affinity to Human immunodeficiency virus 1 protease by SPR biosensor interaction analysis at pH 5.1 | | AID | 673197 | | BioAssay type | Literature | | Target | | | PubMed | 22743085 | | Data Table |  |
|
| 19 | [SID103759741] | Active | Ki | 0.0032 | Inhibition of HIV1 recombinant protease A71V/V82T/I84V mutant expressed in Escherichia coli by spectrophotometric assay [AID343017, Type: Literature] | |   View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.0032 [uM] | | BioAssay | Inhibition of HIV1 recombinant protease A71V/V82T/I84V mutant expressed in Escherichia coli by spectrophotometric assay | | AID | 343017 | | BioAssay type | Literature | | Target | | | PubMed | 18598016 | | Data Table |  |
|
| 20 | [SID103759741] | Active | Kd | 0.0034 | Binding affinity to Human immunodeficiency virus 1 protease by SPR biosensor interaction analysis at pH 7.4 [AID673196, Type: Literature] | |   View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Kd | 0.0034 [uM] | | BioAssay | Binding affinity to Human immunodeficiency virus 1 protease by SPR biosensor interaction analysis at pH 7.4 | | AID | 673196 | | BioAssay type | Literature | | Target | | | PubMed | 22743085 | | Data Table |  |
|
| 21 | [SID103759741] | Active | Ki | 0.0038 | Inhibition of HIV1 recombinant protease M46I/A71V/V82T/I84V mutant expressed in Escherichia coli by spectrophotometric assay [AID343016, Type: Literature] | |   View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.0038 [uM] | | BioAssay | Inhibition of HIV1 recombinant protease M46I/A71V/V82T/I84V mutant expressed in Escherichia coli by spectrophotometric assay | | AID | 343016 | | BioAssay type | Literature | | Target | | | PubMed | 18598016 | | Data Table |  |
|
| 22 | [SID103759741] | Active | EC50 | 0.0054 | Antiviral activity against wild type HIV1 [AID321685, Type: Literature] | |   View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.0054 [uM] | | BioAssay | Antiviral activity against wild type HIV1 | | AID | 321685 | | BioAssay type | Literature | | Target | | | PubMed | 17981045 | | Data Table |  |
|
| 23 | [SID103759741] | Active | EC50 | 0.0057 | Antiviral activity against wild type HIV1 subtype CRF02_AG infected in human cord blood mononuclear cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay [AID547002, Type: Literature] | |   View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.0057 [uM] | | BioAssay | Antiviral activity against wild type HIV1 subtype CRF02_AG infected in human cord blood mononuclear cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay | | AID | 547002 | | BioAssay type | Literature | | Target | | | PubMed | 20404123 | | Data Table |  |
|
| 24 | [SID103759741] | Active | EC50 | 0.0058 | Antiviral activity against wild type HIV1 NL4-3 in HEK293 cells after 48 hrs by replication-defective luciferase reporter gene-based phenotypic assay [AID374600, Type: Literature] | |   View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.0058 [uM] | | BioAssay | Antiviral activity against wild type HIV1 NL4-3 in HEK293 cells after 48 hrs by replication-defective luciferase reporter gene-based phenotypic assay | | AID | 374600 | | BioAssay type | Literature | | Target | | | PubMed | 17638694 | | Data Table |  |
|
| 25 | [SID103759741] | Active | IC50 | 0.007 | Antiviral activity against HIV1 BA-L isolate in human PHA-PBMC cells [AID269306, Type: Literature] | |   View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.007 [uM] | | BioAssay | Antiviral activity against HIV1 BA-L isolate in human PHA-PBMC cells | | AID | 269306 | | BioAssay type | Literature | | Target | | | PubMed | 16913714 | | Data Table |  |
|
| 26 | [SID103759741] | Active | IC50 | 0.009 | Inhibition of wild type HIV-1 protease assessed as hydrolysis of fluorogenic substrate Abz-Thr-Ile-Nle-Phe(NO2)-Gln-Arg after 10 mins by fluorescence assay [AID656209, Type: Literature] | |   View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.009 [uM] | | BioAssay | Inhibition of wild type HIV-1 protease assessed as hydrolysis of fluorogenic substrate Abz-Thr-Ile-Nle-Phe(NO2)-Gln-Arg after 10 mins by fluorescence assay | | AID | 656209 | | BioAssay type | Literature | | Target | | | PubMed | 22414613 | | Data Table |  |
|
| 27 | [SID103759741] | Active | EC50 | 0.0098 | Antiviral activity against wild type HIV1 subtype B infected in human cord blood mononuclear cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay [AID546992, Type: Literature] | |   View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.0098 [uM] | | BioAssay | Antiviral activity against wild type HIV1 subtype B infected in human cord blood mononuclear cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter gene assay | | AID | 546992 | | BioAssay type | Literature | | Target | | | PubMed | 20404123 | | Data Table |  |
|
| 28 | [SID103759741] | Active | IC50 | 0.01 | Antiviral activity against HIV1 isolate 5512 with M36I/M and V82T mutation in CBMCs [AID279348, Type: Literature] | |   View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Antiviral activity against HIV1 isolate 5512 with M36I/M and V82T mutation in CBMCs | | AID | 279348 | | BioAssay type | Literature | | Target | | | PubMed | 17116674 | | Data Table |  |
|
| 29 | [SID103759741] | Active | IC50 | 0.01 | Antiviral activity against HIV1 LAI isolate in human MT2 cells [AID269304, Type: Literature] | |   View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.01 [uM] | | BioAssay | Antiviral activity against HIV1 LAI isolate in human MT2 cells | | AID | 269304 | | BioAssay type | Literature | | Target | | | PubMed | 16913714 | | Data Table |  |
|
| 30 | [SID103759741] | Active | Ki | 0.01 | Inhibition of HIV1 recombinant protease V32I/I47A mutant expressed in Escherichia coli by spectrophotometric assay [AID343018, Type: Literature] | |   View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.01 [uM] | | BioAssay | Inhibition of HIV1 recombinant protease V32I/I47A mutant expressed in Escherichia coli by spectrophotometric assay | | AID | 343018 | | BioAssay type | Literature | | Target | | | PubMed | 18598016 | | Data Table |  |
|
| 31 | [SID103759741] | Active | EC50 | 0.011 | Antiviral activity against HIV1 NL4-3 harboring L10F/L33F/M46I/I47V/Q58E/V82I/I84V/I85V amino acid substitution in protease encoding region infected in human MT4 cells assessed as inhibition of p24 Gag protein production selected at 5 uM of GRL-02031 by ELISA [AID557292, Type: Literature] | |   View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.011 [uM] | | BioAssay | Antiviral activity against HIV1 NL4-3 harboring L10F/L33F/M46I/I47V/Q58E/V82I/I84V/I85V amino acid substitution in protease encoding region infected in human MT4 cells assessed as inhibition of p24 Gag protein production selected at 5 uM of GRL-02031 by ELISA | | AID | 557292 | | BioAssay type | Literature | | Target | | | PubMed | 18955518 | | Data Table |  |
|
| 32 | [SID103759741] | Active | IC50 | 0.012 | Antiviral activity against R5 tropic HIV1 Ba-L infected in human PBMC assessed as inhibition of HIN p24 antigen expression [AID568182, Type: Literature] | |   View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.012 [uM] | | BioAssay | Antiviral activity against R5 tropic HIV1 Ba-L infected in human PBMC assessed as inhibition of HIN p24 antigen expression | | AID | 568182 | | BioAssay type | Literature | | Target | | | PubMed | 21256008 | | Data Table |  |
|
| 33 | [SID103759741] | Active | IC50 | 0.012 | Antiviral activity against HIV1 Ba-L(R5) infected in human PBMC by p24 antigen capture assay [AID454923, Type: Literature] | |   View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.012 [uM] | | BioAssay | Antiviral activity against HIV1 Ba-L(R5) infected in human PBMC by p24 antigen capture assay | | AID | 454923 | | BioAssay type | Literature | | Target | | | PubMed | 20005712 | | Data Table |  |
|
| 34 | [SID103759741] | Active | IC50 | 0.012 | Antiviral activity against R5 tropic HIV1 Ba-L infected PBMC assessed as inhibition of viral p24 antigen expression [AID612003, Type: Literature] | |   View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.012 [uM] | | BioAssay | Antiviral activity against R5 tropic HIV1 Ba-L infected PBMC assessed as inhibition of viral p24 antigen expression | | AID | 612003 | | BioAssay type | Literature | | Target | | | PubMed | 21658961 | | Data Table |  |
|
| 35 | [SID103759741] | Active | IC50 | 0.012 | Antiviral activity against HIV1 BAL by p24 assay [AID492209, Type: Literature] | |   View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.012 [uM] | | BioAssay | Antiviral activity against HIV1 BAL by p24 assay | | AID | 492209 | | BioAssay type | Literature | | Target | | | PubMed | 20542438 | | Data Table |  |
|
| 36 | [SID103759741] | Active | EC50 | 0.013 | Antiviral activity against HIV1 harboring capsid I201V mutant protein infected in human HeLa cells assessed as decrease in viral infection after 72 hrs by beta-galactosidase reporter gene assay [AID562702, Type: Literature] | |   View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.013 [uM] | | BioAssay | Antiviral activity against HIV1 harboring capsid I201V mutant protein infected in human HeLa cells assessed as decrease in viral infection after 72 hrs by beta-galactosidase reporter gene assay | | AID | 562702 | | BioAssay type | Literature | | Target | | | PubMed | 19805571 | | Data Table |  |
|
| 37 | [SID103759741] | Active | IC50 | 0.014 | Antiviral activity against HIV1 LAI isolate in human PHA-PBMC cells [AID269305, Type: Literature] | |   View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.014 [uM] | | BioAssay | Antiviral activity against HIV1 LAI isolate in human PHA-PBMC cells | | AID | 269305 | | BioAssay type | Literature | | Target | | | PubMed | 16913714 | | Data Table |  |
|
| 38 | [SID103759741] | Active | IC50 | 0.014 | Antiviral activity against wild type HIV1 in CBMCs [AID279345, Type: Literature] | |   View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.014 [uM] | | BioAssay | Antiviral activity against wild type HIV1 in CBMCs | | AID | 279345 | | BioAssay type | Literature | | Target | | | PubMed | 17116674 | | Data Table |  |
|
| 39 | [SID103759741] | Active | EC50 | 0.015 | Antiviral activity against wild type HIV1 ERS104prc X4 in phytohemagglutinin-activated PBMCs assessed as inhibition of p24 Gag protein expression by MTT assay [AID322112, Type: Literature] | |   View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.015 [uM] | | BioAssay | Antiviral activity against wild type HIV1 ERS104prc X4 in phytohemagglutinin-activated PBMCs assessed as inhibition of p24 Gag protein expression by MTT assay | | AID | 322112 | | BioAssay type | Literature | | Target | | | PubMed | 17371811 | | Data Table |  |
|
| 40 | [SID103759741] | Active | EC50 | 0.016 | Antiviral activity against HIV1 3B in MT4 cells by MTT assay [AID290994, Type: Literature] | |   View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.016 [uM] | | BioAssay | Antiviral activity against HIV1 3B in MT4 cells by MTT assay | | AID | 290994 | | BioAssay type | Literature | | Target | | | PubMed | 17537628 | | Data Table |  |
|
| 41 | [SID103759741] | Active | EC50 | 0.016 | Antiviral activity against HIV1 3B in human MT4 cells assessed as inhibition of viral-induced cytopathic effect by MTT method [AID408207, Type: Literature] | |   View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.016 [uM] | | BioAssay | Antiviral activity against HIV1 3B in human MT4 cells assessed as inhibition of viral-induced cytopathic effect by MTT method | | AID | 408207 | | BioAssay type | Literature | | Target | | | PubMed | 18426195 | | Data Table |  |
|
| 42 | [SID103759741] | Active | EC50 | 0.016 | Antiviral activity against wild type HIV1 infected in human HeLa cells assessed as decrease in viral infection after 72 hrs by beta-galactosidase reporter gene assay [AID562701, Type: Literature] | |   View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.016 [uM] | | BioAssay | Antiviral activity against wild type HIV1 infected in human HeLa cells assessed as decrease in viral infection after 72 hrs by beta-galactosidase reporter gene assay | | AID | 562701 | | BioAssay type | Literature | | Target | | | PubMed | 19805571 | | Data Table |  |
|
| 43 | [SID103759741] | Active | EC50 | 0.016 | Antiviral activity against HIV1 ERS104pre infected in human PHA-PBC assessed as inhibition of p24 Gag protein production by ELISA [AID553574, Type: Literature] | |   View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.016 [uM] | | BioAssay | Antiviral activity against HIV1 ERS104pre infected in human PHA-PBC assessed as inhibition of p24 Gag protein production by ELISA | | AID | 553574 | | BioAssay type | Literature | | Target | | | PubMed | 18955518 | | Data Table |  |
|
| 44 | [SID103759741] | Active | Ki | 0.016 | Dissociation constant obtained by inhibition of mutant HIV-protease (A-44) [AID225562, Type: Literature] | |   View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.016 [uM] | | BioAssay | Dissociation constant obtained by inhibition of mutant HIV-protease (A-44) | | AID | 225562 | | BioAssay type | Literature | | Target | | | PubMed | 10978186 | | Data Table |  |
|
| 45 | [SID103759741] | Active | EC50 | 0.018 | Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as inhibition of p24 gag protein production by ELISA [AID557284, Type: Literature] | |   View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.018 [uM] | | BioAssay | Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as inhibition of p24 gag protein production by ELISA | | AID | 557284 | | BioAssay type | Literature | | Target | | | PubMed | 18955518 | | Data Table |  |
|
| 46 | [SID103759741] | Active | EC50 | 0.018 | Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay [AID369838, Type: Literature] | |   View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.018 [uM] | | BioAssay | Antiviral activity against HIV1 NL4-3 infected in human MT4 cells assessed as reduction in virus-induced cytopathic effect after 5 days by MTT assay | | AID | 369838 | | BioAssay type | Literature | | Target | | | PubMed | 17576848 | | Data Table |  |
|
| 47 | [SID103759741] | Active | EC50 | 0.018 | Antiviral activity against HIV1 BaL R5 subtype B in phytohemagglutinin-activated PBMCs assessed as inhibition of p24 Gag protein expression by MTT assay [AID322121, Type: Literature] | |   View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.018 [uM] | | BioAssay | Antiviral activity against HIV1 BaL R5 subtype B in phytohemagglutinin-activated PBMCs assessed as inhibition of p24 Gag protein expression by MTT assay | | AID | 322121 | | BioAssay type | Literature | | Target | | | PubMed | 17371811 | | Data Table |  |
|
| 48 | [SID103759741] | Active | Ki | 0.018 | Inhibition of HIV1 recombinant protease D30N/N88D mutant expressed in Escherichia coli by spectrophotometric assay [AID343015, Type: Literature] | |   View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | Ki | 0.018 [uM] | | BioAssay | Inhibition of HIV1 recombinant protease D30N/N88D mutant expressed in Escherichia coli by spectrophotometric assay | | AID | 343015 | | BioAssay type | Literature | | Target | | | PubMed | 18598016 | | Data Table |  |
|
| 49 | [SID103759741] | Active | EC50 | 0.019 | Antiviral activity against HIV1 3B [AID321661, Type: Literature] | |   View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | EC50 | 0.019 [uM] | | BioAssay | Antiviral activity against HIV1 3B | | AID | 321661 | | BioAssay type | Literature | | Target | | | PubMed | 17981045 | | Data Table |  |
|
| 50 | [SID103759741] | Active | IC50 | 0.02 | Antiviral activity against HIV2 EHO isolate in human MT2 cells [AID269307, Type: Literature] | |   View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 103759741 | | CID | 10578931 | | Outcome | Active | | IC50 | 0.02 [uM] | | BioAssay | Antiviral activity against HIV2 EHO isolate in human MT2 cells | | AID | 269307 | | BioAssay type | Literature | | Target | | | PubMed | 16913714 | | Data Table |  |
|